Jeff Yass’s Bicycle Therapeutics BCYC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$447K Buy
121,350
+89,393
+280% +$362K ﹤0.01% 10047
2026
Q2
$135K Sell
31,957
-5,931
-16% -$27.2K ﹤0.01% 12280
2026
Q1
$176K Sell
37,888
-70,535
-65% -$403K ﹤0.01% 11829
2025
Q4
$768K Buy
108,423
+81,794
+307% +$603K ﹤0.01% 7794
2025
Q3
$206K Buy
26,629
+62
+0.2% +$468 ﹤0.01% 10933
2025
Q2
$185K Buy
+26,567
New +$212K ﹤0.01% 11292
2024
Q1
– Sell
-24,535
Closed -$521K – 12168
2023
Q4
$444K Sell
24,535
-41,146
-63% -$681K ﹤0.01% 8967
2023
Q3
$1.32M Buy
65,681
+3,017
+5% +$69K ﹤0.01% 6007
2023
Q2
$1.6M Buy
62,664
+18,091
+41% +$420K ﹤0.01% 5620
2023
Q1
$948K Buy
44,573
+7,518
+20% +$189K ﹤0.01% 6968
2022
Q4
$1.1M Buy
+37,055
New +$994K ﹤0.01% 5978
2021
Q4
– Sell
-18,475
Closed -$1.02M – 13102
2021
Q3
$768K Buy
+18,475
New +$646K ﹤0.01% 8242

Other funds holding BCYC

Jeff Yass's BCYC Position: Q3 2026 in Review

Jeff Yass increased its Bicycle Therapeutics (BCYC) stake by 280% in Q3 2026, buying an estimated $362K and bringing the position to 121,350 shares worth $447K. The position accounts for ﹤0.01% of the portfolio, ranked #10047.

Jeff Yass first reported a position in BCYC in Q3 2021 and has held it in 12 quarters since. The position peaked at $1.6M in Q2 2023. 88 funds tracked by Wall St. Rank hold BCYC as of Q3 2026.

  • Jeff Yass held 121,350 shares of Bicycle Therapeutics worth $447K as of Q3 2026.
  • Jeff Yass bought 89,393 Bicycle Therapeutics shares in Q3 2026, an estimated $362K.
  • Bicycle Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #10047 holding.
  • Jeff Yass first reported a position in Bicycle Therapeutics in Q3 2021 and has held it in 12 quarters since.
  • Jeff Yass's Bicycle Therapeutics position peaked at $1.6M in Q2 2023.
  • 88 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.